Back to Journals » OncoTargets and Therapy » Volume 6

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

Total article views   HTML views PDF downloads Totals
10,802 Dovepress* 9,703+ 1,440 11,143
PubMed Central* 1,099 397 1,496
Totals 10,802 1,837 12,639
*Since 29 November 2013
+Since July 2016

View citations on PubMed Central and Google Scholar